META_DESC_INVESTMENT_IDEA ...

ILMN teams up with NVIDIA to advance technology platforms for the analysis and interpretation of multiomic data.

The company revealed plans to increase the usage of AI in pharma at JP Morgan’s healthcare conference in San Francisco.

The process started almost two years before we sat in the car at CES 2025, and it was important for the team to get it right.

Illumina will offer its DRAGEN analysis software on Nvidia’s accelerated computing platforms through the next-gen sequencing ...

Illumina & NVIDIA collaborate to decode biology and propel precision health: San Diego Wednesday, January 15, 2025, 16:00 Hrs [IST] Illumina, Inc., a global leader in genomic sequ ...

The latest edition of STAT’s Health Tech newsletter brings you important dispatches from the J.P. Morgan Health Care ...

J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' biggest wheelers ...

Nvidia said that it has partnered with companies and organizations in the life sciences industry to use generative AI to ...

The global Spatial Genomics & Transcriptomics market is expected to grow to USD 995.7 Million by 2029, up from USD 554.5 ...

NVIDIA starts 2025 by announcing a trio of partnerships and a research collaboration to boost healthcare sector presence.

Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and interpretation ...